{"id":"medication-for-opioid-use-disorder","safety":{"commonSideEffects":[{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Sedation"},{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"Withdrawal symptoms"}]},"_chembl":null,"_fixedAt":"2026-03-30T17:19:55.114302","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The most common marketed medications for opioid use disorder include methadone (a full mu-opioid agonist that prevents withdrawal and reduces cravings), buprenorphine (a partial mu-opioid agonist with lower overdose risk), and naltrexone (a mu-opioid antagonist that blocks opioid effects). These agents target opioid receptors in the central nervous system to either substitute for illicit opioids, reduce withdrawal symptoms, or prevent reinforcement of opioid use.","oneSentence":"Opioid use disorder medications work by binding to opioid receptors to reduce cravings, prevent withdrawal, or block the euphoric effects of opioids.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:54:13.925Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Opioid use disorder"}]},"_fixedFields":["pubmed(901)"],"trialDetails":[{"nctId":"NCT07498322","phase":"NA","title":"Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2026-06-01","conditions":"Opiod Use Disorder","enrollment":271031},{"nctId":"NCT03745339","phase":"","title":"Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder","status":"RECRUITING","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2019-06-07","conditions":"Opioid-Related Disorders, Drug Addiction","enrollment":150},{"nctId":"NCT06496230","phase":"EARLY_PHASE1","title":"Open Trial of Technology-Enhanced Behavioral Intervention for Buprenorphine Retention in Pregnant and Postpartum People","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2024-08-06","conditions":"Opioid Use Disorder, Pregnancy Related","enrollment":15},{"nctId":"NCT05834478","phase":"PHASE3","title":"Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3","status":"RECRUITING","sponsor":"Emory University","startDate":"2024-02-20","conditions":"Withdrawal Symptoms, Opioid Use Disorder, Opioid Use","enrollment":103},{"nctId":"NCT06524232","phase":"NA","title":"The STop UNhealthy Substance Use Now Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University","startDate":"2024-09-16","conditions":"Risky Health Behavior, Substance Use Disorders, Substance Abuse","enrollment":144},{"nctId":"NCT07179614","phase":"NA","title":"Kentucky Women's Justice Community Overdose Innovation Network - Phase II","status":"NOT_YET_RECRUITING","sponsor":"Michele Staton","startDate":"2026-04-15","conditions":"Overdose Risk, Opioid Use Disorder, Stimulant Use Disorders","enrollment":300},{"nctId":"NCT05688410","phase":"NA","title":"Enhancing Exercise and Psychotherapy to Treat Pain and Addiction in Adults With an Opioid Use Disorder (EXPO; R33 Phase)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Case Western Reserve University","startDate":"2023-02-10","conditions":"Opioid Use Disorder, Pain","enrollment":198},{"nctId":"NCT04736550","phase":"NA","title":"Enhancing Exercise and Psychotherapy to Treat Pain and Addiction in Opioid Use Disorders (\"EXPO\" Pilot Trial)","status":"COMPLETED","sponsor":"Case Western Reserve University","startDate":"2021-01-08","conditions":"Opioid-use Disorder, Pain","enrollment":63},{"nctId":"NCT07485335","phase":"PHASE4","title":"A Bundled Intervention - Phase 2","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-09-07","conditions":"Opioid Use Disorder, Opioid Overdose","enrollment":160},{"nctId":"NCT06157840","phase":"NA","title":"Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2025-08-25","conditions":"Opioid Use Disorder, Poor Quality Sleep","enrollment":40},{"nctId":"NCT05529927","phase":"PHASE2","title":"Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Parnassia Addiction Research Centre","startDate":"2026-05","conditions":"Cocaine Use Disorder","enrollment":204},{"nctId":"NCT07456930","phase":"","title":"Real-World Evaluation of Compl-AI for Predicting Early Medication Dropout in Opioid Use Disorder Treatment","status":"NOT_YET_RECRUITING","sponsor":"Tools4Patient","startDate":"2026-06-01","conditions":"Opioid Use Disorder","enrollment":295},{"nctId":"NCT03895827","phase":"NA","title":"Recovery Initiation and Management After Overdose (RIMO) Experiment","status":"COMPLETED","sponsor":"Chestnut Health Systems","startDate":"2022-04-01","conditions":"Opioid-use Disorder","enrollment":251},{"nctId":"NCT06848504","phase":"NA","title":"MedSMA℞T Mobile ED","status":"NOT_YET_RECRUITING","sponsor":"Olufunmilola Abraham","startDate":"2026-09","conditions":"Opiate-Related Disorders, Opiate Use Disorder, Opioid","enrollment":244},{"nctId":"NCT03911466","phase":"","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study","status":"COMPLETED","sponsor":"T. John Winhusen, PhD","startDate":"2020-07-21","conditions":"Opioid-Related Disorders, Drug Addiction, Pregnancy Related","enrollment":97},{"nctId":"NCT03911739","phase":"","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study","status":"COMPLETED","sponsor":"T. John Winhusen, PhD","startDate":"2021-06-14","conditions":"Opioid-Related Disorders, Drug Addiction, Pregnancy Related","enrollment":71},{"nctId":"NCT07469501","phase":"PHASE4","title":"Comparing Outpatient Treatment Retention Among Individuals Using Fentanyl Randomized to Low-dose and Direct-to-inject Buprenorphine Initiation","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-06","conditions":"Opioid Use Disorder, Fentanyl","enrollment":50},{"nctId":"NCT07466784","phase":"","title":"CEDRN: Opioid Registry","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-07-24","conditions":"Opioid Use Disorder, Opioid Abuse or Dependence, Opioid Withdrawal","enrollment":7200},{"nctId":"NCT06835751","phase":"NA","title":"Optimizing HIV Pre-exposure Prophylaxis (PrEP) Among Women Who Use Drugs in Tanzania","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2025-07-25","conditions":"HIV, Mental Health, Substance Use (Drugs, Alcohol)","enrollment":200},{"nctId":"NCT05722561","phase":"PHASE2","title":"E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2024-08-08","conditions":"Opioid Use Disorder, Cigarette Smoking","enrollment":302},{"nctId":"NCT06341608","phase":"NA","title":"Improving Access to Opioid Use Disorder Treatment Among Marginalized Patients With a Tailored Telehealth Intervention","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-04-15","conditions":"Opioid Use Disorder","enrollment":60},{"nctId":"NCT04712981","phase":"NA","title":"Adapting the HOPE Online Support Intervention to Increase Uptake of Medications for Opioid Use Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Irvine","startDate":"2021-04-29","conditions":"Opioid Use Disorder","enrollment":640},{"nctId":"NCT04839978","phase":"NA","title":"Community Trial in the Cherokee Nation","status":"COMPLETED","sponsor":"Emory University","startDate":"2021-09-29","conditions":"Opioid Abuse","enrollment":919},{"nctId":"NCT07451197","phase":"NA","title":"Family-Focused Study to Support Medication for Opioid Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2027-07","conditions":"Opioid Use Disorder, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe","enrollment":338},{"nctId":"NCT06948890","phase":"NA","title":"Effect of Music on Cue Reactivity for Patients With Opioid Use Disorder","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2025-04-20","conditions":"Opioid Use Disorder","enrollment":28},{"nctId":"NCT07073924","phase":"NA","title":"Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-08-01","conditions":"People Who Use Opioids/People With Opioid Use Disorder (OUD)","enrollment":536},{"nctId":"NCT06992427","phase":"PHASE3","title":"High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer","status":"RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2025-06-05","conditions":"Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8","enrollment":228},{"nctId":"NCT07224009","phase":"PHASE2","title":"Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)","status":"NOT_YET_RECRUITING","sponsor":"University of Arkansas","startDate":"2026-03","conditions":"Metastatic Prostate Cancer","enrollment":60},{"nctId":"NCT07232641","phase":"","title":"Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic","status":"NOT_YET_RECRUITING","sponsor":"Boston University","startDate":"2026-04","conditions":"Substance Use Disorders, Alcohol Use Disorder, Opioid Use Disorder","enrollment":185810},{"nctId":"NCT07439549","phase":"PHASE4","title":"Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial","status":"NOT_YET_RECRUITING","sponsor":"Pouya Azar","startDate":"2026-02-18","conditions":"Opioid Use Disorder","enrollment":12},{"nctId":"NCT05492825","phase":"NA","title":"IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs","status":"RECRUITING","sponsor":"Albert Einstein College of Medicine","startDate":"2023-02-27","conditions":"Substance Use Disorders, Chronic Pain, Opioid Use Disorder","enrollment":180},{"nctId":"NCT06837662","phase":"NA","title":"The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2025-03-24","conditions":"Opioid Dependence, Substance Abuse Disorders, Complex Medical Patients","enrollment":70},{"nctId":"NCT06696066","phase":"NA","title":"PEERS Pilot: Peer Recovery Support Program to Support Engagement in Medication for Opioid Use Disorder","status":"COMPLETED","sponsor":"Geisinger Clinic","startDate":"2025-02-18","conditions":"Opioid Use Disorder","enrollment":13},{"nctId":"NCT07432555","phase":"NA","title":"Testing a Mobile Health Application to Improve HIV Prevention and Substance Use Treatment Among Women Involved in the Carceral System","status":"NOT_YET_RECRUITING","sponsor":"Temple University","startDate":"2026-03","conditions":"Substance Abuse, HIV","enrollment":74},{"nctId":"NCT06005662","phase":"PHASE2","title":"Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2027-04","conditions":"Opioid Use Disorder","enrollment":""},{"nctId":"NCT07071766","phase":"NA","title":"Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment","status":"NOT_YET_RECRUITING","sponsor":"University of Arkansas","startDate":"2026-03-01","conditions":"Substance Use Treatment, Perinatal Substance Use, Parenting","enrollment":10},{"nctId":"NCT04804072","phase":"NA","title":"INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit","status":"COMPLETED","sponsor":"HIV Prevention Trials Network","startDate":"2021-06-02","conditions":"HIV Infections, Drug Use, Opioid Use","enrollment":447},{"nctId":"NCT06187064","phase":"NA","title":"Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington","status":"COMPLETED","sponsor":"University of Washington","startDate":"2024-03-18","conditions":"Opioid Use Disorder, HIV Infections, Chlamydia","enrollment":50},{"nctId":"NCT06134882","phase":"NA","title":"OUD Smartphone Services","status":"ACTIVE_NOT_RECRUITING","sponsor":"Western Michigan University","startDate":"2024-04-23","conditions":"Opioid-Related Disorders, Drug Abuse","enrollment":250},{"nctId":"NCT06827288","phase":"NA","title":"Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder","status":"RECRUITING","sponsor":"RAND","startDate":"2024-10-04","conditions":"Opioid Use Disorder","enrollment":500},{"nctId":"NCT05991622","phase":"PHASE2","title":"Combined Injectable Treatment for HIV and OUD","status":"WITHDRAWN","sponsor":"Rhode Island Hospital","startDate":"2022-04-01","conditions":"Human Immunodeficiency Virus, Opioid Use Disorder","enrollment":""},{"nctId":"NCT07088770","phase":"NA","title":"TechMPower: Advancing HIV/SUD Care and Service Delivery for People in Re-entry","status":"COMPLETED","sponsor":"Columbia University","startDate":"2024-11-22","conditions":"HIV (Human Immunodeficiency Virus), Substance Abuse Disorder","enrollment":65},{"nctId":"NCT07197801","phase":"NA","title":"Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment","status":"RECRUITING","sponsor":"Geisinger Clinic","startDate":"2025-12-23","conditions":"Opioid Use Disorder","enrollment":218},{"nctId":"NCT05706311","phase":"NA","title":"Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2025-01-21","conditions":"Opioid Abuse, Prescription Opioid Abuse","enrollment":80},{"nctId":"NCT06854029","phase":"PHASE4","title":"NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-06","conditions":"HIV Infections, Opioid Use Disorder, Incarceration; Lens","enrollment":300},{"nctId":"NCT07409350","phase":"NA","title":"A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs","status":"NOT_YET_RECRUITING","sponsor":"NYU Langone Health","startDate":"2027-01","conditions":"Substance Use, HIV Prevention","enrollment":398},{"nctId":"NCT06969261","phase":"NA","title":"Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-01-01","conditions":"Perinatal Opioid Use Disorder, Opioid Use Disorder","enrollment":20},{"nctId":"NCT04245423","phase":"NA","title":"The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2020-12-15","conditions":"Opioid-use Disorder, Mental Health Conditions","enrollment":567},{"nctId":"NCT04276259","phase":"PHASE4","title":"Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses","status":"COMPLETED","sponsor":"Marta Peciña, MD PhD","startDate":"2020-10-19","conditions":"Major Depressive Disorder, Depression","enrollment":120},{"nctId":"NCT07406828","phase":"PHASE1","title":"Psilocybin After Trauma Surgery for Pain","status":"NOT_YET_RECRUITING","sponsor":"Trent Emerick","startDate":"2026-07","conditions":"Pain Management, Postoperative Pain","enrollment":70},{"nctId":"NCT04325659","phase":"PHASE2, PHASE3","title":"An Innovative Intervention for OUD Treatment","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2020-11-15","conditions":"Opioid-Related Disorders, Opioid Dependence, Opioid Addiction","enrollment":46},{"nctId":"NCT05180669","phase":"NA","title":"Reward-based Technology to Improve OUD Treatment","status":"TERMINATED","sponsor":"Q2i, LLC","startDate":"2022-11-18","conditions":"Opioid Use Disorder","enrollment":41},{"nctId":"NCT06857968","phase":"NA","title":"Mobile Mindfulness Training (mMT) for People in Medication Treatment of Opioid Use Disorder (MOUD)","status":"ENROLLING_BY_INVITATION","sponsor":"Amy Meadows","startDate":"2025-07-29","conditions":"Opioid Use Disorder","enrollment":60},{"nctId":"NCT07064564","phase":"PHASE1","title":"iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Akyso Therapeutics, LLC","startDate":"2026-04-01","conditions":"Opioid Use Disorder","enrollment":33},{"nctId":"NCT05051644","phase":"PHASE1","title":"An Adaptive Walking Intervention to Manage Chronic Pain in Veterans With Opioid Use Disorder Engaged in Opioid Agonist Treatment","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2022-04-01","conditions":"Opioid Use Disorder, Chronic Pain","enrollment":60},{"nctId":"NCT05405712","phase":"NA","title":"Mobile Peer Support for OUD Recovery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brown University","startDate":"2022-05-12","conditions":"Opioid Use Disorder","enrollment":1300},{"nctId":"NCT07361432","phase":"PHASE3","title":"Digital Treatment for Chronic Pain and Addiction in Veterans With Opioid Use Disorder Receiving Buprenorphine","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-11-02","conditions":"Opioid Use Disorder, Chronic Pain","enrollment":250},{"nctId":"NCT05380440","phase":"NA","title":"Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: PRE-FAIR","status":"COMPLETED","sponsor":"Chestnut Health Systems","startDate":"2021-06-09","conditions":"Opioid-Related Disorders, Stimulant-Related Disorder, Child Neglect","enrollment":241},{"nctId":"NCT05063201","phase":"PHASE2","title":"Cariprazine for Comorbid Cocaine and Opioid Use Disorder","status":"COMPLETED","sponsor":"Kyle Kampman","startDate":"2022-08-05","conditions":"Opioid-use Disorder, Cocaine Use Disorder","enrollment":26},{"nctId":"NCT05878210","phase":"","title":"Evaluating the SUBLOCADE Treatment Exit Strategy","status":"COMPLETED","sponsor":"Indivior Inc.","startDate":"2023-11-24","conditions":"Opioid Use Disorder","enrollment":12},{"nctId":"NCT07350148","phase":"NA","title":"Opioid Adherence and Support Through Innovative Texting Strategies","status":"RECRUITING","sponsor":"University of New Mexico","startDate":"2025-10-13","conditions":"Opioid Use Disorder (OUD), Chronic Pain","enrollment":60},{"nctId":"NCT07342504","phase":"NA","title":"Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment","status":"RECRUITING","sponsor":"University of Notre Dame","startDate":"2026-01-21","conditions":"Alcohol Use Disorder, Opioid Use Disorder, Alcohol Use","enrollment":60},{"nctId":"NCT04375033","phase":"PHASE4","title":"A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2020-11-03","conditions":"Opioid Use Disorder","enrollment":952},{"nctId":"NCT05646212","phase":"NA","title":"Integrating Treatment for Mental Disorders in Methadone Clinics in Ukraine","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ukrainian Institute on Public Health Policy","startDate":"2018-07-01","conditions":"Depression, Opioid Use Disorder","enrollment":1350},{"nctId":"NCT07322588","phase":"NA","title":"Reentry Incentives and Support for Engagement With Contingency Management","status":"NOT_YET_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2026-01-01","conditions":"Opioid Use Disorder","enrollment":75},{"nctId":"NCT05064826","phase":"NA","title":"ED Observation for Opioid Use Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2022-04-21","conditions":"Opioid Use Disorder","enrollment":170},{"nctId":"NCT06023459","phase":"PHASE3","title":"Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yih-Ing Hser","startDate":"2024-10-14","conditions":"Opioid-Related Disorders, Substance-Related Disorders, Narcotic-Related Disorders","enrollment":144},{"nctId":"NCT03729180","phase":"NA","title":"The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2019-01-22","conditions":"Surgery","enrollment":1900},{"nctId":"NCT05300581","phase":"NA","title":"Determining the Feasibility of Outpatient Parenteral Antibiotic Therapy for Persons Who Inject Opioids","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2022-03-16","conditions":"Opioid Use Disorder","enrollment":10},{"nctId":"NCT03734731","phase":"NA","title":"Cannabis Vs Opioids Pain Management Objective Testing Comparisons","status":"NOT_YET_RECRUITING","sponsor":"American Association of Sensory Electrodiagnostic Medicine","startDate":"2026-06-03","conditions":"Chronic Pain, Circulatory Disorders","enrollment":1000},{"nctId":"NCT05546515","phase":"PHASE2","title":"Suvorexant for Opioid/Stimulant Co-use","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2022-12-01","conditions":"Opioid Use Disorder, Stimulant Use Disorder","enrollment":20},{"nctId":"NCT06130501","phase":"NA","title":"tAN for PTSD and OUD in Buprenorphine Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cincinnati","startDate":"2024-07-01","conditions":"Posttraumatic Stress Disorder, Opioid Use Disorder","enrollment":20},{"nctId":"NCT04648228","phase":"NA","title":"Pain and Opioids: Integrated Treatment In Veterans","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of New Mexico","startDate":"2021-07-01","conditions":"Chronic Pain, Opioid-use Disorder, Opioids; Harmful Use","enrollment":157},{"nctId":"NCT07079826","phase":"NA","title":"Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Payel Roy","startDate":"2026-02-21","conditions":"Opioid Withdrawal, Opioid Use Disorder (OUD)","enrollment":50},{"nctId":"NCT03568552","phase":"NA","title":"Patient Decision Aid for Opioid Use Disorder","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2020-08-03","conditions":"Opioid Use Disorder","enrollment":7554},{"nctId":"NCT06027814","phase":"NA","title":"MHealth Incentivized Adherence Plus Patient Navigation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Washington","startDate":"2024-01-03","conditions":"Opioid Use Disorder, Medication Adherence, Polysubstance Drug Use (Indiscriminate Drug Use)","enrollment":40},{"nctId":"NCT06799702","phase":"NA","title":"Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)","status":"NOT_YET_RECRUITING","sponsor":"University of Georgia","startDate":"2026-08-01","conditions":"HIV Pre-exposure Prophylaxis, HEPATITIS C (HCV), Opioid Use Disorder","enrollment":50},{"nctId":"NCT07085377","phase":"NA","title":"Autonomous Methadone Delivery System by Nurses","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2025-12-08","conditions":"Opioid Use Disorder (OUD), Addictology","enrollment":182},{"nctId":"NCT04464980","phase":"PHASE2","title":"Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2021-06-08","conditions":"Opioid Use Disorder (OUD)","enrollment":1516},{"nctId":"NCT05766631","phase":"PHASE3","title":"Treating Polysubstance Use Using a Novel Digital Technology","status":"RECRUITING","sponsor":"Friends Research Institute, Inc.","startDate":"2023-07-26","conditions":"Opioid Use, Opioid Use Disorder, Cocaine Use","enrollment":240},{"nctId":"NCT07178990","phase":"NA","title":"Mobile Platform for Optimizing Wellness and Engagement in Recovery","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2025-12-08","conditions":"Opioid Agonist Treatment, Alcohol Use Disorder, Opioid Use Disorder","enrollment":50},{"nctId":"NCT06766331","phase":"NA","title":"Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2028-04-03","conditions":"Opioid Use Disorder, HIV, Hepatitis C Virus","enrollment":60},{"nctId":"NCT03150173","phase":"PHASE2","title":"Onsite Buprenorphine Treatment at Syringe Exchange Programs","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2019-01-02","conditions":"Opiate Addiction","enrollment":97},{"nctId":"NCT06526286","phase":"","title":"Clinical Decision Support to Increase Use of Medications for Opioid Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-02","conditions":"Medication Abuse, Harm Reduction, Opioid Use Disorder","enrollment":200000},{"nctId":"NCT06271668","phase":"","title":"Clinical Decision Support to Improve System Naloxone Co-prescribing","status":"ENROLLING_BY_INVITATION","sponsor":"University of Colorado, Denver","startDate":"2024-07-01","conditions":"Medication Abuse, Harm Reduction, Opioid Overdose","enrollment":200000},{"nctId":"NCT04345718","phase":"PHASE2, PHASE3","title":"EXHIT ENTRE Comparative Effectiveness Trial","status":"COMPLETED","sponsor":"Gavin Bart","startDate":"2021-08-09","conditions":"Substance Use Disorder, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe","enrollment":344},{"nctId":"NCT05585229","phase":"PHASE2","title":"Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-10-27","conditions":"Opioid Dependence, Chronic Pain","enrollment":10},{"nctId":"NCT06136247","phase":"","title":"Integrating Brain, Neurocognitive, and Computational Tools in OUD","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2023-11-01","conditions":"Opioid Use Disorder","enrollment":192},{"nctId":"NCT06593353","phase":"NA","title":"Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail","status":"RECRUITING","sponsor":"University of Washington","startDate":"2024-11-21","conditions":"Opioid Use Disorder, Opioid Use Disorders","enrollment":4165},{"nctId":"NCT06416020","phase":"NA","title":"Integrating MOUD in Nonmedical Community Settings (Better Together)","status":"NOT_YET_RECRUITING","sponsor":"Howard University","startDate":"2026-01-26","conditions":"Opioid Use Disorder","enrollment":400},{"nctId":"NCT06641115","phase":"NA","title":"Integrated Treatment for Opioid Use Disorder and PTSD","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2025-03-01","conditions":"Opioid Use Disorder, Posttraumatic Stress Disorder (PTSD)","enrollment":76},{"nctId":"NCT06999811","phase":"NA","title":"Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2025-11-05","conditions":"Opioid Use Disorder, Pregnancy","enrollment":37},{"nctId":"NCT06774248","phase":"NA","title":"Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD","status":"RECRUITING","sponsor":"Potomac Health Foundations","startDate":"2025-02-01","conditions":"Opioid Use Disorder","enrollment":80},{"nctId":"NCT07216963","phase":"NA","title":"The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-09","conditions":"Opioid Use Disorder, Overdose, Drug, Overdose","enrollment":400},{"nctId":"NCT07043452","phase":"EARLY_PHASE1","title":"Measuring Acute Drug Demand in Humans II","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2025-11-15","conditions":"Healthy Volunteers","enrollment":""},{"nctId":"NCT06534905","phase":"NA","title":"E-cigarette Switching Older Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2024-11-25","conditions":"Tobacco Use, Opioid Use Disorder, Tobacco-Related Disorders","enrollment":36},{"nctId":"NCT05776966","phase":"NA","title":"Women's Opioid Treatment Follow-up Study","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2024-03-08","conditions":"Opioid Use Disorder","enrollment":39},{"nctId":"NCT07011758","phase":"PHASE2","title":"Dynamic Treatment Regimes for Opioid Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2028-07-01","conditions":"Opioid Use Disorder","enrollment":75},{"nctId":"NCT06732596","phase":"NA","title":"Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents","status":"RECRUITING","sponsor":"Boston Medical Center","startDate":"2025-10-30","conditions":"Opioid Use Disorder","enrollment":100},{"nctId":"NCT06513156","phase":"NA","title":"Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use","status":"RECRUITING","sponsor":"Elana Rosenthal","startDate":"2024-10-01","conditions":"Opioid Use Disorder, Injection Related Infections, Stimulant Use Disorder","enrollment":304}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":901,"recentPublications":[{"date":"2026 Mar 24","pmid":"41875249","title":"A Case of 7-Hydroxymitragynine Use Disorder Treated With Buprenorphine.","journal":"Journal of addiction medicine"},{"date":"2026 Feb","pmid":"41869237","title":"Barriers to Buprenorphine Prescribing for Opioid Use Disorder Among Louisiana Family Physicians: A Pilot Survey Study With Narrative Review.","journal":"Cureus"},{"date":"2026 Mar 19","pmid":"41862055","title":"Geospatial ecological momentary assessment (GEMA) for opioid use disorder: Protocol for a just-in-time adaptive intervention.","journal":"Journal of substance use and addiction treatment"},{"date":"2026 Mar 16","pmid":"41850520","title":"Randomized controlled pilot trial of extended-release buprenorphine vs. sublingual buprenorphine-naloxone in rural settings (RXR): Study rationale and design.","journal":"Contemporary clinical trials"},{"date":"2026 Mar 2","pmid":"41838002","title":"Treating Opioid Use Disorder With Methadone in Pharmacies.","journal":"JAMA network open"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["methadone","buprenorphine/naloxone","Behavioral Drug and Risk Counseling"],"phase":"marketed","status":"active","brandName":"medication for opioid use disorder","genericName":"medication for opioid use disorder","companyName":"University of Pennsylvania","companyId":"university-of-pennsylvania","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Opioid use disorder medications work by binding to opioid receptors to reduce cravings, prevent withdrawal, or block the euphoric effects of opioids. Used for Opioid use disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}